After surgery, they all recovered from hypogonadism and the whole group experienced a significant increase in total and free testosterone and FSH concentrations, which indicates an improvement of the hormonal pattern characteristic of the obesity-related secondary hypogonadism (MOSH). The gene discussed is BRD2; the disease is hypogonadotropic hypogonadism.